UBX Unity Biotechnology Inc.

8.04
+0.03  (+0%)
Previous Close 8.01
Open 8.03
Price To Book 2.15
Market Cap 344775937
Shares 42,856,993
Volume 87,389
Short Ratio
Av. Daily Volume 170,742

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1 data due 2Q 2019.
UBX0101
Osteoarthritis

Latest News

  1. UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Program Updates
  2. UNITY Biotechnology, Inc. to Participate in the Cowen 39th Annual Health Care Conference
  3. CORRECTING and REPLACING -- UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2018 Financial Results
  4. UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2018 Financial Results
  5. The Daily Biotech Pulse: PTC Therapeutics, Select Biosciences Offering, Unity Biotech Expands Early-Stage Osteoarthritis Drug Study
  6. UNITY Biotechnology Expands Ongoing UBX0101 Phase 1 Study to Further Evaluate SASP Factors in Osteoarthritis of the Knee
  7. Ascentage Pharma Announces New License with Unity Biotechnology
  8. UNITY Biotechnology Announces Completion of UBX1967 License and Advance into IND-Enabling Studies for Age-Related Diseases of the Eye
  9. This year's Bay Area IPO batch remains up 44% despite market turbulence
  10. UNITY (UBX) Soars: Stock Adds 5.1% in Session
  11. UNITY Biotechnology, Inc. Appoints Margo Roberts Ph.D. to Board of Directors
  12. The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO
  13. UNITY Biotechnology Announces Additional Cohort to Evaluate Higher Dose in Ongoing UBX0101 Phase 1 Study in Osteoarthritis of the Knee
  14. UNITY Biotechnology, Inc. to Host Investor & Analyst Event on Cellular Senescence
  15. UNITY Biotechnology, Inc. Reports Third Quarter 2018 Financial Results
  16. UNITY Biotechnology, Inc. to Announce Third Quarter 2018 Financial Results
  17. 24 Bay Area companies have gone public so far this year. Here's how they've done.
  18. Do You Know Who Else Invests In Unity Biotechnology Inc (NASDAQ:UBX)?
  19. Today’s Research Reports on Stocks to Watch: Unity Biotechnology and Principia Biopharma